Agenus Inc (AGEN)

12:05 PM

Breakthrough Cancer Drug Data: Agenus to Present 3 New Studies on Botensilimab at ASCO 2025 - Stock Titan

12:05 PM

12:04 PM

Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025 - The Joplin Globe

12:04 PM

Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025

Apr 21, 2025

Agenus (AGEN) Price Target Slashed by B. Riley Analyst, Buy Rating Maintained | AGEN Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

B. Riley Cuts Price Target on Agenus to $8 From $11, Keeps Buy Rating - marketscreener.com

Apr 21, 2025

Apr 17, 2025

Agenus Inc. (AGEN) to Present Key Cancer Research at AACR Meeting - GuruFocus

Apr 17, 2025

Apr 10, 2025

AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025

Apr 10, 2025

AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025

Apr 08, 2025

AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 08, 2025

Apr 07, 2025

Agenus stock hits 52-week low at $1.44 amid sharp annual decline - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

Agenus stock hits 52-week low at $1.44 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 03, 2025

AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Agenus Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

Agenus Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire

Apr 03, 2025

Mar 31, 2025

Agenus stock hits 52-week low at $1.53 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Agenus stock hits 52-week low at $1.53 amid sharp annual decline - Investing.com India

Mar 31, 2025

Mar 25, 2025

Breakthrough Cancer Treatment Data: Agenus BOT/BAL Shows Promise Across Multiple Cancers - Stock Titan

Mar 25, 2025

Mar 25, 2025

Here's Why Agenus (AGEN) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

Mar 25, 2025

Mar 20, 2025

Agenus stock hits 52-week low at $1.64 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Agenus stock hits 52-week low at $1.64 amid sharp annual decline - Investing.com Australia

Mar 20, 2025

Mar 19, 2025

Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation - Lelezard

Mar 19, 2025

Mar 19, 2025

93% of Doctors Say Current Colorectal Cancer Treatments Fall Short, New Study Shows - Stock Titan

Mar 19, 2025

Mar 18, 2025

H.C. Wainwright maintains neutral on Agenus stock post-10-K filing - Investing.com Australia

Mar 18, 2025

Mar 17, 2025

AGENUS INC SEC 10-K Report - TradingView

Mar 17, 2025

Mar 17, 2025

Gilead Sciences : Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead - Marketscreener.com

Mar 17, 2025

Mar 16, 2025

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 16, 2025

Mar 14, 2025

Equities Analysts Offer Predictions for Agenus Q1 Earnings - Defense World

Mar 14, 2025

Mar 14, 2025

HC Wainwright Reaffirms Neutral Rating for Agenus (NASDAQ:AGEN) - Defense World

Mar 14, 2025

Mar 13, 2025

Agenus stock falls after revenue miss - MSN

Mar 13, 2025

Mar 13, 2025

Agenus (AGEN) Q4 2024 Earnings Call Transcript - AOL

Mar 13, 2025

Mar 12, 2025

Agenus stock hits 52-week low at $1.91 amid market challenges - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

Earnings call transcript: Agenus sees stock jump in Q4 2024 By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

Agenus Inc. Earnings Call: Mixed Sentiments and Strategic Focus - TipRanks

Mar 12, 2025

Mar 12, 2025

Agenus stock hits 52-week low at $1.91 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 12, 2025

Agenus Inc. (NASDAQ:AGEN) Q4 2024 Earnings Call Transcript - MSN

Mar 12, 2025

Mar 12, 2025

Agenus’ Strategic Cost Reductions and CRC Focus Lead to Hold Rating - TipRanks

Mar 12, 2025

Mar 12, 2025

Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges - Yahoo

Mar 12, 2025

Mar 12, 2025

Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Mo - GuruFocus.com

Mar 12, 2025

Mar 12, 2025

Agenus Inc. Reports Strategic Cost Reductions and BOT/BAL Progress - TipRanks

Mar 12, 2025

Mar 11, 2025

Agenus: Q4 Earnings Snapshot - mySA

Mar 11, 2025

Mar 11, 2025

Agenus stock falls as Q4 revenue drops sharply - Investing.com India

Mar 11, 2025

Mar 11, 2025

Agenus stock falls as Q4 revenue drops sharply By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 11, 2025

Earnings call transcript: Agenus sees stock jump in Q4 2024 - Investing.com India

Mar 11, 2025

Mar 11, 2025

Agenus Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 11, 2025